Total hip replacement is a frequently done and highly successful surgical intervention. The
procedure is undertaken to relieve pain and improve function in individuals with advanced …

BACKGROUND With the increasing complexity of surgical interventions performed in
orthopaedic trauma surgery and the improving technologies used in three-dimensional (3D) …

Background A growing body of published research on tranexamic acid (TXA) suggests that it
is effective in reducing blood loss and the risk for transfusion in total knee arthroplasty (TKA) …

Background Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce
blood loss in total hip arthroplasty (THA). The purpose of our study was to evaluate the …

Background Tranexamic acid (TXA) has demonstrated efficacy in reducing blood loss,
reduction in hemoglobin, and blood transfusion requirements in primary total hip …

Background: Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss
and the need for transfusions when administered intravenously in total hip arthroplasty. Oral …

Aims We chose unstable extra-capsular hip fractures as our study group because these
types of fractures suffer the largest blood loss. We hypothesised that tranexamic acid (TXA) …

Aims The purpose of the present study was to evaluate the impact of intravenous tranexamic
acid on the reduction of blood loss, transfusion rate, and early post-operative clinical …

Background Tranexamic acid (TXA) is a synthetic antifibrinolytic agent successfully used
intravenously (IV) to reduce blood loss after total knee arthroplasty (TKA). An oral …

Background Postoperative complications and perioperative transfusions are common after
hemiarthroplasty or total hip arthroplasty (THA) and can lead to increased morbidity and …